scholarly journals Diana’s Diabetes by W. J. Hall

2018 ◽  
Vol 8 (2) ◽  
Author(s):  
Victoria Eke
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Medical Procedures ◽  
Self Monitoring ◽  
Book Series ◽  
Information Session ◽  
Medical Identification ◽  
Source Of Information

Hall, Wendy J. Diana’s Diabetes. CreateSpace Independent Publishing Platform, 2018. As part of the Mediwonderland book series designed to “guide children through common medical procedures and illnesses”, Diana’s Diabetes follows the journey of Diana, a young girl recently diagnosed with Type 1 diabetes, as she learns about her condition and how it is managed. Following the identification of symptoms and her initial diagnosis, Diana and her mother return to the clinic for an information session and follow-up with Dr. Daniel and Nurse Nina. There, Diana and her mother learn about the mechanics of the illness, self-monitoring for blood glucose, and insulin injections. Diana is also given a journal in which she must record her food intake and insulin doses, as well as a medical identification bracelet. Major concepts are introduced through text and accompanying illustrations. The text, printed in large font, is easy to read. The content is rolled out logically, allowing for one concept to build upon the previous. Colourful illustrations by Ysha Morco serve to complement the text, providing visuals for the various concepts presented. However, in the case of the “Type 1 Diabetes” poster illustrated on pages 15 and 16, more detail and additional labels could have been added to better explain the biology behind the illness. In addition to providing an informative and factually sound overview of Type 1 diabetes in children, author Wendy J. Hall has successfully created characters and a scenario that will undoubtedly resonate with patients and family members alike, serving as both a source of information and comfort. This book is highly recommended for public, elementary school, and children’s hospital libraries.  Highly Recommended: 4 out of 4 starsReviewer: Victoria Eke

Accuracy of Blood Glucose Meters for Self-Monitoring Affects Glucose Control and Hypoglycemia Rate in Children and Adolescents with Type 1 Diabetes

2015 ◽  
Vol 17 (4) ◽  
pp. 275-282 ◽  
Author(s):  
Claudia Boettcher ◽  
Axel Dost ◽  
Stefan A. Wudy ◽  
Marion Flechtner-Mors ◽  
Martin Borkenstein ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Children And Adolescents ◽  
Glucose Control ◽  
Self Monitoring

scholarly journals Use of Ecological Momentary Assessment to Measure Self-Monitoring of Blood Glucose Adherence in Youth With Type 1 Diabetes

2020 ◽  
Vol 33 (3) ◽  
pp. 280-289 ◽  
Author(s):  
Jennifer L. Warnick ◽  
Sarah C. Westen ◽  
Anastasia Albanese-O’Neill ◽  
Stephanie L. Filipp ◽  
Desmond Schatz ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Ecological Momentary Assessment ◽  
Self Monitoring ◽  
Ecological Momentary ◽  
Momentary Assessment

scholarly journals Knowledge and Demand for Information about Islet Transplantation in Patients with Type 1 Diabetes

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Yuko Yamamoto ◽  
Masakazu Nishigaki ◽  
Naoko Kato ◽  
Michio Hayashi ◽  
Teruo Shiba ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Islet Transplantation ◽  
Cross Sectional Study ◽  
Sources Of Information ◽  
Related Factors ◽  
Cross Sectional ◽  
Self Monitoring ◽  
High Level ◽  
Source Of Information

This cross-sectional study based on self-administrated questionnaire was conducted to investigate knowledge, related factors, and sources of information regarding islet transplantation in patients with type 1 diabetes in Japan. Among 137 patients who provided valid responses, 67 (48.9%) knew about islet transplantation. Their main source of information was newspapers or magazines (56.7%) and television or radio (46.3%). However, 85.8% of patients preferred the attending physician as their source of information. Although more than half of the patients were correctly aware of issues related to islet transplantation, the following specific issues for islet transplantation were not understood or considered, and there was little knowledge of them: need for immunosuppressants, lifestyle and dietary adaptations, fewer bodily burdens, and complications. The experience of hypoglycaemia, a high level of academic background, frequent self-monitoring of blood glucose, and the use of continuous subcutaneous insulin infusion were related to higher knowledge about islet transplantation.

scholarly journals Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden

2017 ◽  
Vol 5 (1) ◽  
pp. e000342 ◽  
Author(s):  
Peter Moström ◽  
Elsa Ahlén ◽  
Henrik Imberg ◽  
Per-Olof Hansson ◽  
Marcus Lind
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Self Monitoring

Frequency and motives of blood glucose self-monitoring in type 1 diabetes

2009 ◽  
Vol 85 (2) ◽  
pp. 183-188 ◽  
Author(s):  
M.V. Hansen ◽  
U. Pedersen-Bjergaard ◽  
S.R. Heller ◽  
T.M. Wallace ◽  
Å.K. Rasmussen ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Self Monitoring ◽  
Blood Glucose Self Monitoring

scholarly journals The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

2020 ◽  
Author(s):  
Shilan Seyed Ahmadi ◽  
Klara Westman ◽  
Aldina Pivodic ◽  
Arndís F Ólafsdóttir ◽  
Sofia Dahlqvist ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Conventional Therapy ◽  
Self Monitoring ◽  
Glucose Levels ◽  
Daily Insulin ◽  
Multiple Daily Insulin Injections ◽  
Mean Glucose ◽  
Hba1c Levels

<b><i>Objective: </i></b>According to recent guidelines, individuals with type 1 diabetes should spend less than 4.0% per day with glucose levels <3.9 mmol/L (<70 mg/dL) and less than 1.0% per day <3.0 mmol/L (<54 mg/dL). <p><b><i><br> Research methods: </i></b>In the GOLD randomised cross-over trial, 161 individuals with type 1 diabetes treated with multiple daily insulin injections (MDI) were randomised to Continuous Glucose Monitoring (CGM) or conventional therapy with self-monitoring of blood glucose (SMBG) and evaluated over 16 months. We estimated the association between time spent in hypoglycaemia and various mean glucose and HbA1c levels.</p> <p> </p> <p><b><i>Results: </i></b>Time spent in hypoglycaemia (<3.9 mmol/L and <3.0 mmol/L) increased significantly with lower mean HbA1c and mean glucose levels during both CGM and conventional therapy. During CGM, 24 (57.1%) individuals with HbA1c <7.5 % (<58 mmol/mol) had <1.0% time spent in hypoglycaemia <3.0 mmol/L and 23 (54.8%) had <4.0% time spent in hypoglycaemia <3.9 mmol/L. During CGM, mean time spent in hypoglycaemia for individuals with mean HbA1c 7.0% (52 mmol/mol) was estimated to be 5.4% for <3.9 mmol/L and 1.5% for <3.0 mmol/L. The corresponding values during SMBG were 9.2% and 3.5%, respectively. Individuals with mean glucose levels of 8 mmol/L spent 4.9% more time with glucose levels <3.9 mmol/L and 2.8% more time <3.0 mmol/L during SMBG compared with CGM.</p> <p> </p> <p><b><i>Conclusions: </i></b>Reaching current targets for time in hypoglycaemia and at the same time HbA1c targets is challenging for type 1 diabetes patients treated with MDI both with CGM and SMBG monitoring. However, CGM is associated with considerably less time in hypoglycaemia than SMBG at a broad range of HbA1c levels and is crucial for patients with MDI treatment to have a chance to approach hypoglycaemia targets.</p>

scholarly journals The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

2020 ◽  
Author(s):  
Shilan Seyed Ahmadi ◽  
Klara Westman ◽  
Aldina Pivodic ◽  
Arndís F Ólafsdóttir ◽  
Sofia Dahlqvist ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Conventional Therapy ◽  
Self Monitoring ◽  
Glucose Levels ◽  
Daily Insulin ◽  
Multiple Daily Insulin Injections ◽  
Mean Glucose ◽  
Hba1c Levels

<b><i>Objective: </i></b>According to recent guidelines, individuals with type 1 diabetes should spend less than 4.0% per day with glucose levels <3.9 mmol/L (<70 mg/dL) and less than 1.0% per day <3.0 mmol/L (<54 mg/dL). <p><b><i><br> Research methods: </i></b>In the GOLD randomised cross-over trial, 161 individuals with type 1 diabetes treated with multiple daily insulin injections (MDI) were randomised to Continuous Glucose Monitoring (CGM) or conventional therapy with self-monitoring of blood glucose (SMBG) and evaluated over 16 months. We estimated the association between time spent in hypoglycaemia and various mean glucose and HbA1c levels.</p> <p> </p> <p><b><i>Results: </i></b>Time spent in hypoglycaemia (<3.9 mmol/L and <3.0 mmol/L) increased significantly with lower mean HbA1c and mean glucose levels during both CGM and conventional therapy. During CGM, 24 (57.1%) individuals with HbA1c <7.5 % (<58 mmol/mol) had <1.0% time spent in hypoglycaemia <3.0 mmol/L and 23 (54.8%) had <4.0% time spent in hypoglycaemia <3.9 mmol/L. During CGM, mean time spent in hypoglycaemia for individuals with mean HbA1c 7.0% (52 mmol/mol) was estimated to be 5.4% for <3.9 mmol/L and 1.5% for <3.0 mmol/L. The corresponding values during SMBG were 9.2% and 3.5%, respectively. Individuals with mean glucose levels of 8 mmol/L spent 4.9% more time with glucose levels <3.9 mmol/L and 2.8% more time <3.0 mmol/L during SMBG compared with CGM.</p> <p> </p> <p><b><i>Conclusions: </i></b>Reaching current targets for time in hypoglycaemia and at the same time HbA1c targets is challenging for type 1 diabetes patients treated with MDI both with CGM and SMBG monitoring. However, CGM is associated with considerably less time in hypoglycaemia than SMBG at a broad range of HbA1c levels and is crucial for patients with MDI treatment to have a chance to approach hypoglycaemia targets.</p>

Sign in / Sign up

Export Citation Format

Share Document